Latest

May 10, 2018, 10:30 ET Impulse Dynamics Publishes FIX-HF-5C Clinical Trial Results

Impulse Dynamics (USA), Inc. announced results from its FIX-HF-5C randomized, Controlled Trial of Cardiac Contractility Modulation in Heart Failure....


Dec 18, 2017, 08:05 ET Impulse Dynamics' Optimizer® Receives CFDA Approval in China

The China Food and Drug Administration (CFDA) has approved Impulse Dynamics' Optimizer® system for treatment of chronic heart failure. The...


May 11, 2017, 11:05 ET Impulse Dynamics Completes $45 Million Financing Round

Impulse Dynamics, developer of the revolutionary Cardiac Contractility Modulation (CCM) technology for treatment of Chronic Heart Failure (CHF),...


May 13, 2016, 11:05 ET Impulse Dynamics Completes $30 Million Financing Round

Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company...